Novo Nordisk chair foresees pressure on pharmaceutical industry

Chair of the Novo Nordisk Board Helge Lund thinks tax payers will be paying a large bill for the Covid-19 crisis. He also expects an additional pressure to fall on the pharmaceutical industry in future years.
Photo: Novo Nordisk Pharmatech/PR
Photo: Novo Nordisk Pharmatech/PR
BY RITZAU FINANS, TRANSLATED BY NIELSINE NIELSEN

Novo Nordisk's Chair of the Board Helge Lund predicts that Danish tax payers will, to a large extent, be paying the bills for the coronavirus crisis in this country, but that the pharmaceutical industry will also be put under pressure, according to Danish media Finans.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
!
!
Must contain at least 6 characters
!
Must contain at least 2 characters
!
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

!
Newsletter terms

Front page now

Further reading